Archives of Dermatological Research is a premier journal dedicated to the rapidly evolving field of dermatology, published by Springer. With a distinguished history dating back to 1971 and indexed in the top quartiles (Q1 in Dermatology and Q2 in Medicine, 2023), this journal serves as a vital resource for researchers, clinicians, and students alike. It publishes innovative findings, critical reviews, and comprehensive studies that advance our understanding of dermatological conditions and treatments. The journal's commitment to disseminating high-quality research in a field crucial to public health emphasizes the importance of advancing knowledge in skin science and therapy. For those looking to explore significant advancements in dermatology, Archives of Dermatological Research offers an invaluable platform for scholarly discourse and knowledge exchange, though it is not an Open Access journal. Based in Germany, this publication attracts a global audience and remains at the forefront of dermatological research until its anticipated converged years reaching 2024.

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

SKIN RESEARCH AND TECHNOLOGY, a distinguished publication by Wiley, stands at the forefront of dermatological science, emphasizing innovative research and technological advances in skin health. With an ISSN of 0909-752X and an E-ISSN of 1600-0846, this journal serves as a vital platform for researchers and professionals to present their findings and engage in discussions surrounding skin biology, clinical practices, and therapeutic technologies. As evidenced by its respectable Q2 ranking in the dermatology category for 2023 and a Q3 status in miscellaneous medicine, the journal attracts a broad readership and contributes significantly to the field. Housed in the United Kingdom with publications spanning from 1995 to 2024, SKIN RESEARCH AND TECHNOLOGY continues to foster innovation and knowledge dissemination in skin-related research. While its Access options are not open, the impact of the journal remains prominent, appealing to academic professionals and students eager to explore emerging trends and advancements in dermatological studies.

JAMA Dermatology, an esteemed publication by the American Medical Association, is positioned at the forefront of dermatological research and clinical practice. With an ISSN of 2168-6068 and an E-ISSN of 2168-6084, this journal underscores a commitment to disseminating high-quality and impactful research within the field. Notably ranked Q1 in both Dermatology and Miscellaneous Medicine for 2023, JAMA Dermatology ranks among the top journals in its category, holding the impressive 3rd position out of 142 in Scopus's dermatology rankings, placing it in the 98th percentile. With converged years extending from 2013 to 2024, the journal emphasizes timely and critical advancements in dermatological science. Furthermore, as a champion of open access, it encourages a broad dissemination of knowledge, making essential research accessible to a wider audience. Researchers, professionals, and students alike will find JAMA Dermatology to be an invaluable resource for the latest findings, innovative therapies, and in-depth reviews that shape the future of dermatological health.

SKIN PHARMACOLOGY AND PHYSIOLOGY is a leading peer-reviewed journal published by KARGER, based in Switzerland, that focuses on the intricate interplay between skin pharmacology and physiology. With its ISSN 1660-5527 and E-ISSN 1660-5535, the journal spans a rich history of publication since 1988, presenting groundbreaking research and discoveries in the fields of dermatology, pharmacology, and physiology. As evidenced by its 2023 quartile rankings, which include Q2 in Dermatology and Q2 in Medicine (miscellaneous), this journal is highly regarded, ranking in the 83rd percentile for dermatology in Scopus, reflecting its significant impact on the scientific community. Researchers, professionals, and students alike will find valuable insights in this publication, which aims to disseminate knowledge and foster innovations that enhance the understanding of skin-related health. The open access policies provide wider accessibility to relevant findings and developments, making it an essential resource for anyone dedicated to advancing the field.

Turkderm - Turkish Archives of Dermatology and Venerology, published by GALENOS PUBL HOUSE, serves as a vital platform for the dissemination of innovative research and advancements in the fields of dermatology and venerology. With an Open Access policy implemented since 2002, this journal aims to provide free and unrestricted access to significant findings, ensuring that vital information reaches a global audience. Based in Turkey, the journal has positioned itself as an important resource for professionals, researchers, and students alike, despite currently being categorized in Q4 of both Dermatology and Infectious Diseases as per the 2023 metrics. Although it faces competition in the rankings, with a Scopus standing of #131 in Dermatology and #331 in Infectious Diseases, its dedication to advancing knowledge in these critical health areas is unwavering. The journal continually invites original research, reviews, and case studies that enhance clinical practices and foster understanding in the dermatological community.

CLINICAL AND EXPERIMENTAL DERMATOLOGY is a prominent journal in the field of dermatology, published by Oxford University Press. With an ISSN of 0307-6938 and an E-ISSN of 1365-2230, this journal has been a vital resource for researchers and practitioners since its inception in 1976. Recognized as a Q2 journal within the category of dermatology for 2023, it holds a respectable position, ranking #54 among 142 journals in this discipline, placing it in the 62nd percentile on Scopus. The journal is dedicated to publishing high-quality research that spans clinical and experimental aspects of dermatological science, making it an essential source of knowledge for advancing understanding and treatment of skin disorders. Although it operates on a traditional subscription model without open access options, its contributions to the field are significant, influencing both clinical practices and academic research. Researchers, clinicians, and students alike will find vital insights and contemporary themes presented in its pages, supporting ongoing education and innovation in dermatology.

The Journal of Dermatological Science is a premier peer-reviewed publication dedicated to advancing knowledge in the field of dermatology, biochemistry, and molecular biology. Established in 1990 and published by Elsevier Ireland Ltd, this esteemed journal has consistently achieved high academic recognition, securing a Q1 ranking in Dermatology and a Q2 ranking in both Biochemistry and Molecular Biology as of 2023. With a notable impact factor and a Scopus rank that places it within the top tier of dermatology journals globally, it serves as a critical platform for researchers, clinicians, and academicians to disseminate their findings and foster innovation in skin health and disease management. Although the journal is not open access, it provides essential insights into cutting-edge research, clinical practices, and molecular mechanisms underlying dermatological conditions. The Journal of Dermatological Science is not only a vital resource for high-quality articles but also a driving force in shaping the future landscape of dermatological research.

Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.